LocalGlobe

LocalGlobe is one of the most established seed funds in Europe, and any UK founder building serious physician-facing AI tools should have it on the list. The firm was set up by Robin and Saul Klein in London and has spent more than a decade backing first-round companies that later become category-defining names. The brand carries weight; a LocalGlobe lead at seed makes follow-on rounds materially easier because top-tier US and European Series A funds pay attention to what the firm chooses to back.

The thesis is intentionally broad: ambitious founders, often technical, building defensible companies in software, fintech, marketplaces, climate, and digital health. Within healthcare, the team has shown a clear interest in AI-native clinical tools, mental health platforms, women’s health, and infrastructure for healthcare data. They tend to like founders who have a hard-won view on their market, often because they have lived inside it as clinicians, scientists, or operators. Pitches that lean on AI as a buzzword without a sharp wedge into a real workflow do not get far.

Check sizes typically land between one and five million dollars at pre-seed and seed, occasionally as a first cheque before product, more often after a working prototype and early signal. The firm is happy to lead, set terms, and take a board seat, and it consistently follows on through Latitude, its growth-stage vehicle, which gives founders continuity from seed through Series B and beyond. Geography is global on paper but heavily UK and European in practice, with London as the centre of gravity.

The team is a mix of founding partners and a deep bench of investing partners with operator and analyst backgrounds, supported by a tight network of advisors and former LocalGlobe founders. Diligence tends to be conviction-led and fast when the team is excited; slower and more reference-heavy when the market is unfamiliar. Decisions are partner-driven rather than committee-driven, which suits founders who want a clear yes or no.

The most reliable way in is through another founder LocalGlobe has backed; warm intros from respected angels, accelerators, and operator-investors also work well. Cold inbound is read but converts less often than referrals. Approach when you have a clear founding insight, ideally a working prototype, and a credible pull signal from physicians, patients, or paying customers. Bring a sharp two-minute pitch, a clean deck, and a thesis on why the next twelve months matter. The fund is most useful when you are setting up your seed round properly: choose a clear lead, line up high-quality angels around it, and use LocalGlobe’s network for hiring and follow-on introductions. Founders building incremental clinical software with no real wedge or no clinical credibility will struggle to land here; founders with a strong founder-market fit and a real product will find a serious, founder-respecting partner.